Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Runge

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
European Heart Journal|September 1, 1996
The future of thrombolysis in the treatment of acute myocardial infarctionC Bode, M S Runge, R W Smalling
The Journal of Biological Chemistry|November 17, 1995
Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cellsG N Rao, P Delafontaine, M S Runge
The American Journal of Cardiology|February 23, 1995
Role of the thrombin receptor in restenosis and atherosclerosisD Baykal, J F Schmedtje, M S Runge
Annals of Hematology|October 1, 1994
Thrombolytic therapy in acute myocardial infarction--selected recent developmentsC Bode, T K Nordt, M S Runge
Annals of Hematology|January 1, 1996
New approaches in plasminogen activator therapyC Bode, D Gulba, K Huber, et al.
Bioconjugate Chemistry|September 1, 1991
Conjugation of plasminogen activators and fibrin-specific antibodies to improve thrombolytic therapeutic agentsD J Hayzer, I M Lubin, M S Runge
Biochemistry|January 6, 1981
Isolation and characterization of neurofilaments from mammalian brainM S Runge, W W Schlaepfer, R C Williams
Trends in Cardiovascular Medicine|January 18, 2011
Strategies for the design of novel thrombolytic and antithrombolytic agentsI M Lubin, D J Hayzer, M S Runge
Thrombosis and Haemostasis|March 1, 2000
Prevention of restenosis after percutaneous coronary interventions: the medical approachS Rosanio, M Tocchi, C Patterson, et al.
Molecular Biology & Medicine|April 1, 1991
Hybrid molecules: insights into plasminogen activator functionM S Runge, C Bode, E Haber, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
European Heart Journal|September 1, 1996
The future of thrombolysis in the treatment of acute myocardial infarctionC Bode, M S Runge, R W Smalling
The Journal of Biological Chemistry|November 17, 1995
Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cellsG N Rao, P Delafontaine, M S Runge
The American Journal of Cardiology|February 23, 1995
Role of the thrombin receptor in restenosis and atherosclerosisD Baykal, J F Schmedtje, M S Runge
Annals of Hematology|October 1, 1994
Thrombolytic therapy in acute myocardial infarction--selected recent developmentsC Bode, T K Nordt, M S Runge
Annals of Hematology|January 1, 1996
New approaches in plasminogen activator therapyC Bode, D Gulba, K Huber, et al.
Bioconjugate Chemistry|September 1, 1991
Conjugation of plasminogen activators and fibrin-specific antibodies to improve thrombolytic therapeutic agentsD J Hayzer, I M Lubin, M S Runge
Biochemistry|January 6, 1981
Isolation and characterization of neurofilaments from mammalian brainM S Runge, W W Schlaepfer, R C Williams
Trends in Cardiovascular Medicine|January 18, 2011
Strategies for the design of novel thrombolytic and antithrombolytic agentsI M Lubin, D J Hayzer, M S Runge
Thrombosis and Haemostasis|March 1, 2000
Prevention of restenosis after percutaneous coronary interventions: the medical approachS Rosanio, M Tocchi, C Patterson, et al.
Molecular Biology & Medicine|April 1, 1991
Hybrid molecules: insights into plasminogen activator functionM S Runge, C Bode, E Haber, et al.
Pageof 14